Filing Details

Accession Number:
0001209191-13-056695
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-12 17:49:25
Reporting Period:
2013-12-12
Filing Date:
2013-12-12
Accepted Time:
2013-12-12 17:49:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453943 Thomas Connolly C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge, MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-12 480 $65.50 3,772 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $65.50 (range $65.16 to $65.72).
  3. Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.